The global pressure ulcers market was valued at $3,720.8 million in 2021, and is projected to reach $5,612.2 million by 2031, registering a CAGR of 4.2% from 2022 to 2031. Pressure ulcers are also called as bed sores, pressure sores or decubitus ulcer are injuries to the skin and tissue due to prolonged pressure or pressure with friction on the skin. Pressure ulcers occurs most commonly on the skin present over sacrum, heels, hips and coccyx. The other affected sites are knees, elbows, ankles and back of cranium. Pressure ulcers develop in individuals who have sedentary lifestyle, continuously use wheelchair and those who are immobilized due to chronic diseases. Early-stage diagnosis enables treatments and reduce complications associated with pressure ulcers such as cellulitis, sepsis, bone and joint infections.
The pressure ulcers market driven by increasing prevalence of pressure ulcer, rise in geriatric population as they are more susceptible to develop pressure ulcers, rise in awareness about availability of treatments for pressure ulcers, and increasing demand for wound care dressings product boosts growth of the market. For instance, according to U.S Department of Health and Human Wound Care Dressings, around 2.5 million population of U.S affected by pressure ulcers in 2020. Moreover, according to Wound Management and Prevention, about 71% pressure ulcers develop in patients older than 70 years.
However, high cost of treatments, side effects associated with the drug treatments such as upset stomach, nausea and blood pressure hinder the growth of the market.
The global pressure ulcers market is segmented into type, treatment type, end user and region. By type the market is categorized into stage 1, stage 2, stage 3, stage 4 and deep tissue injuries. Depending on treatment type, it is fragmented into wound care dressing, wound care devices and others. On the basis of end user, it is divided into hospitals, homecare and others. Region wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Major key players that operate in the global pressure ulcers market are 3M, Abercrombie & Fitch Co (Hollister), Anhui Jinye Industrial Co., Ltd., B. Braun Melungeon AG, Baxter International (Hill-Rom Holdings, Inc), Cardinal Health, Coloplast Group, ConvaTec Group Plc, Essity (BSN medical), Integra LifeSciences (Derma Sciences Inc), Investor AB (Mölnlycke Healthcare AB), Johnson and Johnson, Shandong Chuangkang Biotechnology Co., Ltd., Smith & Nephew plc, Stryker, Tissue Regenix and Wego Group (Foosin Medical Supplies Inc., Ltd.)
The pressure ulcers market driven by increasing prevalence of pressure ulcer, rise in geriatric population as they are more susceptible to develop pressure ulcers, rise in awareness about availability of treatments for pressure ulcers, and increasing demand for wound care dressings product boosts growth of the market. For instance, according to U.S Department of Health and Human Wound Care Dressings, around 2.5 million population of U.S affected by pressure ulcers in 2020. Moreover, according to Wound Management and Prevention, about 71% pressure ulcers develop in patients older than 70 years.
However, high cost of treatments, side effects associated with the drug treatments such as upset stomach, nausea and blood pressure hinder the growth of the market.
The global pressure ulcers market is segmented into type, treatment type, end user and region. By type the market is categorized into stage 1, stage 2, stage 3, stage 4 and deep tissue injuries. Depending on treatment type, it is fragmented into wound care dressing, wound care devices and others. On the basis of end user, it is divided into hospitals, homecare and others. Region wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Major key players that operate in the global pressure ulcers market are 3M, Abercrombie & Fitch Co (Hollister), Anhui Jinye Industrial Co., Ltd., B. Braun Melungeon AG, Baxter International (Hill-Rom Holdings, Inc), Cardinal Health, Coloplast Group, ConvaTec Group Plc, Essity (BSN medical), Integra LifeSciences (Derma Sciences Inc), Investor AB (Mölnlycke Healthcare AB), Johnson and Johnson, Shandong Chuangkang Biotechnology Co., Ltd., Smith & Nephew plc, Stryker, Tissue Regenix and Wego Group (Foosin Medical Supplies Inc., Ltd.)
KEY BENEFITS FOR STAKEHOLDERS
- This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the pressure ulcers market analysis from 2021 to 2031 to identify the prevailing pressure ulcers market opportunities.
- The market research is offered along with information related to key drivers, restraints, and opportunities.
- Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
- In-depth analysis of the pressure ulcers market segmentation assists to determine the prevailing market opportunities.
- Major countries in each region are mapped according to their revenue contribution to the global market.
- Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
- The report includes the analysis of the regional as well as global pressure ulcers market trends, key players, market segments, application areas, and market growth strategies.
Key Market Segments
By Type
- Stage 1
- Stage 2
- Stage 3
- Stage 4
- Deep tissue injury
By Treatment Type
- Wound Care Dressing
- type
- Foam Dressings
- Hydrocolloid Dressings
- Alginate Dressings
- Other Dressings
- Wound Care Devices
- type
- Therapy Devices
- Others
- Others
By End user
- Hospitals
- Homecare
- Others
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of LAMEA
- Asia-Pacific
- Japan
- China
- Australia
- India
- South Korea
- Rest of Asia-Pacific
- LAMEA
- Brazil
- Saudi Arabia
- South Africa
- Rest of LAMEA
Key Market Players
- 3M Company
- Abercrombie & Fitch Co (Hollister)
- Anhui Jinye Industrial Co., Ltd
- B. Braun Melungeon AG
- Baxter International (Hill-Rom Holdings, Inc)
- Cardinal Health Inc.
- Coloplast Group
- ConvaTec Group Plc
- Essity (BSN medical)
- Integra LifeSciences (Derma Sciences Inc)
- Johnson and Johnson
- Smith & Nephew plc
- Stryker Corp
- Tissue Regenix
- Investor AB (Mölnlycke Healthcare AB)
- Wego Group (Foosin Medical Supplies Inc., Ltd.)
- Shandong Chuangkang Biotechnology Co., Ltd.
Table of Contents
CHAPTER 1: INTRODUCTION
CHAPTER 2: EXECUTIVE SUMMARY
CHAPTER 3: MARKET OVERVIEW
CHAPTER 4: PRESSURE ULCERS MARKET, BY TYPE
CHAPTER 5: PRESSURE ULCERS MARKET, BY TREATMENT TYPE
CHAPTER 6: PRESSURE ULCERS MARKET, BY END USER
CHAPTER 7: PRESSURE ULCERS MARKET, BY REGION
CHAPTER 8: COMPANY LANDSCAPE
CHAPTER 9: COMPANY PROFILES
List of Tables
List of Figures
Executive Summary
According to the report, titled, “Pressure Ulcers Market," the pressure ulcers market was valued at $3.7 billion in 2021, and is estimated to reach $5.6 billion by 2031, growing at a CAGR of 4.2% from 2022 to 2031.Pressure ulcers also known as bed sores, pressure injuries or pressure injuries are physiologically painful injuries to the skin that are caused by prolonged pressure applied to the soft tissue or skin. Pressure ulcer can vary in severity from patches of discolored skin to open lesions that expose the muscle or bone. The factors responsible for increasing risk of pressure ulcers are protein-calorie malnutrition, skin wetness caused by sweating, paralysis or neuropathy. Symptoms of pressure ulcers are swelling, painful areas, pus-like effusion, typical changes in color of wound, itching and pain, are all signs of this injury. The treatments for pressure ulcer include dressing of wounds, regularly changing sitting and sleeping positions and use of creams, gels and medicines to increase wound healing. However, pressure ulcers can be very difficult to prevent in critically ill patients if not detected in early stages.
Factors that drive growth of the market include increase in prevalence of stage 2 and stage 3 pressure ulcers, rise in demand for novel wound dressing and devices for the treatment of pressure injuries. In addition, rise in geriatric population, increase in patients seeking treatments for pressure ulcers, and availability of treatments for treating pressure ulcers are some pressure ulcers market trends which further drive market growth. In addition, increase in prevalence of pressure ulcers contributes toward the global market growth. For instance, the rate of pressure ulcers in hospital settings is highest, European hospitals for pressure ulcer patients ranges from 8.3% to 23%. Furthermore, high needs of pressure ulcer treatments and development of novel medications are expected to provide opportunities for market growth. However, expensive treatments for pressure ulcers hinders the growth of the market.
Depending on type, the market is bifurcated into stage 1, stage 2, stage 3, stage 4 and deep tissue injuries. The stage 1 exhibited highest growth in pressure ulcers market size, owing to high prevalence of stage 1 pressure ulcers. However, stage 2 segment is expected to register highest CAGR of 4.8% from 2022-2031, owing to increase in prevalence of stage 2 pressure ulcer, increased used of wound dressings and wound care devices, and rise in geriatric population.
On the basis of treatment type, the market is segmented into wound care dressings, wound care devices and others. Furthermore, the wound care dressings segment was the major revenue contributor in 2021 and drive pressure ulcers market growth, due to increase in demand for wound care dressing such as foam dressings, hydrocolloid dressings, and alginate dressings as a primary treatment for pressure ulcers; high potency of wound care dressings for the treatment of pressure ulcers; and increase in R&D activities for novel wound care dressing products. However, wound care devices segment is expected to register highest CAGR of 5.6% from 2022-2031, owing to increase in demand of wound care devices such as mattress and beds and increase in patients seeking treatments for pressure ulcers, and increase in home-based pressure ulcer treatments.
On the basis of end user, the market is divided into hospitals, homecare, and others. Furthermore, the hospitals segment dominated the market in 2021 and is expected to remain dominant during the forecast period. The market growth of this segment is driven by the increased number of hospitals and patients seeking treatments for pressure ulcer from hospitals. However, homecare segment is expected to register highest CAGR of 5.2% in 2022-2031, owing to increase in prevalence of pressure ulcers among geriatric patients, and increase in patients preferring homecare treatments.
Region wise, North America had the highest pressure ulcers market share in 2021, and is expected to maintain its lead during the forecast period, owing to increasing demands for dressing products and wound care devices for pressure ulcer treatments, increasing prevalence of pressure ulcers, increase in number of approvals for pressure ulcer treatment drugs, and strong presence of key players. However, Asia-Pacific is expected to register highest CAGR of 5.3% in 2022-2031, owing to increase in prevalence of pressure ulcers, rise in patients seeking treatments for pressure ulcers, rise in geriatric populations, and surge in healthcare expenditure.
Key Findings of the Study
- By type, stage 1 dominated the market in 2021.
- On the basis of treatment type, wound care dressing segment dominated in the pressure ulcers industry in 2021.
- By end user, the hospitals segment dominated the market in 2021.
- Region wise, North America dominated the market in 2021 and is expected to grow at a CAGR of 3.4%.
Companies Mentioned
- 3M Company
- Abercrombie & Fitch Co (Hollister)
- Anhui Jinye Industrial Co. Ltd
- B. Braun Melungeon AG
- Baxter International (Hill-Rom Holdings, Inc)
- Cardinal Health Inc.
- Coloplast Group
- Convatec Group plc
- Essity (Bsn Medical)
- Integra Lifesciences (Derma Sciences Inc)
- Johnson and Johnson
- Smith & Nephew plc
- Stryker Corp
- Tissue Regenix
- Investor Ab (Mölnlycke Healthcare Ab)
- Wego Group (Foosin Medical Supplies Inc. Ltd.)
- Shandong Chuangkang Biotechnology Co. Ltd.
Methodology
The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.
They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.
They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:
- Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
- Scientific and technical writings for product information and related preemptions
- Regional government and statistical databases for macro analysis
- Authentic news articles and other related releases for market evaluation
- Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast
Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 321 |
| Published | August 2022 |
| Forecast Period | 2021 - 2031 |
| Estimated Market Value ( USD | $ 3720.8 million |
| Forecasted Market Value ( USD | $ 5612.2 million |
| Compound Annual Growth Rate | 4.2% |
| Regions Covered | Global |
| No. of Companies Mentioned | 17 |
